Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination

Transplant Proc. 1997 Feb-Mar;29(1-2):519-21. doi: 10.1016/s0041-1345(96)00248-5.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepacivirus / isolation & purification
  • Hepatitis C / mortality
  • Hepatitis C / prevention & control*
  • Hepatitis C / surgery*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Liver Transplantation* / mortality
  • Male
  • Middle Aged
  • Pilot Projects
  • RNA, Viral / blood
  • Recombinant Proteins
  • Ribavirin / therapeutic use*
  • Survival Rate
  • Time Factors

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Ribavirin